Air Products & Chemicals, Inc.: Form 10-Q for the period ended Dec 31, 2020
Filed with the SEC on Feb 4, 2021 and accepted by EDGAR at Feb 4, 2021, 11:42 ET.
Management's discussion and analysis
As filed, 41,480 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
| First Quarter 2021 in Summary | 29 |
| First Quarter 2021 Results of Operations | 30 |
| Reconciliations of Non-GAAP Financial Measures | 35 |
| Liquidity and Capital Resources | 38 |
| Contractual Obligations | 40 |
| Pension Benefits | 40 |
| Commitments and Contingencies | 41 |
| Off-Balance Sheet Arrangements | 41 |
| Related Party Transactions | 41 |
| Critical Accounting Policies and Estimates | 41 |
| New Accounting Guidance | 41 |
The discussion that follows should be read in conjunction with the interim consolidated financial statements and the accompanying notes contained in this quarterly report. Unless otherwise stated, financial information is presented in millions of dollars, except for per share data. Except for net income, which includes the results of discontinued operations, financial information is presented on a continuing operations basis. Comparisons of our results of operations and liquidity and capital resources are for the first quarter of fiscal years 2021 and 2020. The disclosures provided in this quarterly report are complementary to those made in our 2020 Form 10-K.
The financial measures discussed below are presented in accordance with U.S. generally accepted accounting principles ("GAAP"), except as noted. We present certain financial measures on an "adjusted" or "non-GAAP" basis because we believe such measures, when viewed together with financial results computed in accordance with GAAP, provide a more complete understanding of the factors and trends affecting our historical financial performance. For each non-GAAP financial measure, including adjusted diluted earnings per share ("EPS"), adjusted EBITDA, adjusted EBITDA margin, and adjusted effective tax rate, we present a reconciliation to the most directly comparable financial measure calculated in accordance with GAAP. These reconciliations and explanations regarding the use of these measures are presented beginning on page 35.
COVID-19 Pandemic
The novel strain of coronavirus ("COVID-19"), which was declared a global pandemic by the World Health Organization in March 2020, continues to impact our business operations and results globally. The health and safety policies we implemented at the beginning of the pandemic have allowed us to safely maintain plant operations and reliably supply critical products and services to our customers. As this significant health crisis continues, we remain focused on business continuity while prioritizing the health and well-being of our people.
As further discussed below, COVID-19 negatively impacted our results of operations during the first three months of fiscal year 2021. Given the dynamic nature of these circumstances, we cannot reasonably estimate the future impact on our ongoing business, results of operations, and overall financial performance.
FIRST QUARTER 2021 VS. FIRST QUARTER 2020
FIRST QUARTER 2021 IN SUMMARY
The results below are compared to the first quarter of fiscal year 2020:
- Sales of $2,375.2 increased 5%, or $120.5, due to favorable currency, pricing actions, and higher energy and natural gas cost pass-through to customers.
- Operating income of $539.1 decreased 4%, or $21.9, and operating margin of 22.7% decreased 220 basis points ("bp").
- Net income of $486.7 was flat, and net income margin of 20.5% decreased 120 bp.
- Adjusted EBITDA of $932.1 increased 3%, or $23.7, and adjusted EBITDA margin of 39.2% decreased 110 bp.
- Diluted EPS of $2.12 decreased 1%, or $0.02 per share. We estimate that COVID-19 negatively impacted our first quarter fiscal year 2021 EPS by approximately $0.10-$0.15 per share. A summary table of changes in diluted EPS is presented below. There were no non-GAAP adjustments in the first quarters of fiscal years 2021 or 2020 that impacted diluted EPS.
Changes in Diluted EPS Attributable to Air Products
The per share impacts presented in the table below were calculated independently and may not sum to the total change in diluted EPS due to rounding.
| Diluted EPS | Three Months Ended 31 December 2020 | 2019 | Increase (Decrease) |
|---|---|---|---|
| Total Diluted EPS | $2.17 | $2.14 | $0.03 |
| Less: Diluted EPS from income from discontinued operations | 0.05 | — | 0.05 |
| Diluted EPS From Continuing Operations | $2.12 | $2.14 | ($0.02) |
| Operating Impacts | |||
| Underlying business | |||
| Volume | ($0.25) | ||
| Price, net of variable costs | 0.17 | ||
| Other costs | (0.06) | ||
| Currency | 0.06 | ||
| Total Operating Impacts | ($0.08) | ||
| Other Impacts | |||
| Equity affiliates' income | $0.04 | ||
| Interest expense | (0.07) | ||
| Other non-operating income (expense), net | 0.04 | ||
| Change in effective tax rate | 0.01 | ||
| Noncontrolling interests | 0.04 | ||
| Total Other Impacts | $0.06 | ||
| Total Change in Diluted EPS From Continuing Operations(A) | ($0.02) |
(A) Includes an estimated negative impact of approximately $0.10-$0.15 from COVID-19, which includes impacts on our sales and costs.
29
FIRST QUARTER 2021 RESULTS OF OPERATIONS
Discussion of Consolidated Results
| GAAP Measures | Three Months Ended 31 December 2020 | 2019 | $ Change | Change |
|---|---|---|---|---|
| Sales | $2,375.2 | $2,254.7 | $120.5 | 5% |
| Operating income | 539.1 | 561.0 | (21.9) | (4%) |
| Operating margin | 22.7% | 24.9% | (220 bp) | |
| Equity affiliates’ income | 69.3 | 58.2 | 11.1 | 19% |
| Net income | 486.7 | 488.9 | (2.2) | —% |
| Net income margin | 20.5% | 21.7% | (120 bp) | |
| Non-GAAP Measures | ||||
| Adjusted EBITDA | $932.1 | $908.4 | $23.7 | 3% |
| Adjusted EBITDA margin | 39.2% | 40.3% | (110 bp) |
Sales
| Sales % Change from Prior Year | |
|---|---|
| Volume | (1)% |
| Price | 2% |
| Energy and natural gas cost pass-through | 1% |
| Currency | 3% |
| Total Consolidated Sales Change | 5% |
Sales of $2,375.2 increased 5%, or $120.5, as favorable currency impacts of 3%, positive pricing of 2%, and higher energy and natural gas cost pass-through of 1% were partially offset by lower volumes of 1%. Favorable currency was driven by the appreciation of the Chinese Renminbi and the Euro against the U.S. Dollar. Continued focus on pricing actions resulted in price improvement in each of the three regional segments. Volumes declined slightly as new plants, acquisitions, and increased sale-of-equipment activities were more than offset by lower demand from COVID-19 and reduced contribution from the long-term onsite customer in Asia discussed below. We estimate that COVID-19 negatively impacted overall sales by approximately 4%.
Lu’An Clean Energy Company (“Lu’An”), a long-term onsite customer in Asia with which we have a consolidated joint venture, has not restarted its facility following the successful major maintenance work completed at the end of fiscal year 2020. In the first quarter of fiscal year 2021, we agreed with the customer to a short-term reduction in rates until market conditions improve. This reduced sales in our Industrial Gases – Asia segment during the three months ended 31 December 2020. We expect the plant to restart during this fiscal year.
Cost of Sales and Gross Margin
Cost of sales of $1,632.4 increased 10%, or $145.8, due to higher costs attributable to sales volumes of $56, negative currency impacts of $44, higher other costs of $27, including planned maintenance, and higher energy and natural gas cost pass-through to customers of $19. Gross margin of 31.3% decreased 280 bp from 34.1% in the prior year, as the impact of our pricing actions was more than offset by unfavorable volume mix and net operating costs.
Selling and Administrative
Selling and administrative expense of $202.7 was flat as lower travel expenses and incentive compensation were offset by higher spending for business development resources to support our growth strategy. Selling and administrative expense as a percentage of sales decreased to 8.5% from 8.9%.
Research and Development
Research and development expense of $23.5 increased 33%, or $5.8, primarily due to higher product development costs. Research and development expense as a percentage of sales increased to 1.0% from 0.8%.
Other Income (Expense), Net
Other income of $22.5 increased 83%, or $10.2, primarily driven by the settlement of a supply contract.
Operating Income and Operating Margin
Operating income of $539.1 decreased 4%, or $21.9, as lower volumes of $71 and higher net operating costs of $15 were partially offset by positive pricing, net of power and fuel costs, of $46 and favorable currency of $18.
Operating margin of 22.7% decreased 220 bp from 24.9% in the prior year, primarily due to lower volumes, including unfavorable volume mix, partially offset by positive pricing.
Equity Affiliates' Income
Equity affiliates' income of $69.3 increased 19%, or $11.1, primarily due to higher income from affiliates in India, Italy, Mexico, and Saudi Arabia.
Interest Expense
| Three Months Ended 31 December 2020 | 2019 | |
|---|---|---|
| Interest incurred | $42.3 | $22.4 |
| Less: Capitalized interest | 5.6 | 3.7 |
| Interest expense | $36.7 | $18.7 |
Interest incurred increased 89%, or $19.9, primarily driven by a higher debt balance due to the issuance of U.S. Dollar- and Euro-denominated fixed-rate notes in the third quarter of fiscal year 2020. Capitalized interest increased 51%, or $1.9, due to a net increase in the carrying value of projects under construction.
Other Non-Operating Income (Expense), Net
Other non-operating income of $18.6 increased $9.5. We recorded higher non-service pension income in 2021 due to lower interest costs and higher total assets, primarily for our U.S. pension plans. The current year also included favorable foreign exchange impacts. These factors were partially offset by lower interest income on cash and cash items.
Discontinued Operations
In the first quarter of fiscal year 2021, we recorded a tax benefit of $10.3 ($0.05 per share) as a component of discontinued operations. This benefit primarily resulted from the settlement of a state tax appeal related to the gain on the sale of our former Performance Materials Division in fiscal year 2017. The benefit is reflected within "Income from discontinued operations, net of tax" on our consolidated income statement for the three months ended 31 December 2020.
Net Income and Net Income Margin
Net income of $486.7, including net income from discontinued operations of $10.3, was flat. Favorable pricing, positive currency, higher equity affiliates' income, and the income from discontinued operations were partially offset by lower volumes and higher costs, including higher planned maintenance. Net income margin of 20.5% decreased 120 bp from 21.7% in the prior year, primarily due to the lower volumes and higher costs, partially offset by higher pricing.
Adjusted EBITDA and Adjusted EBITDA Margin
Adjusted EBITDA of $932.1 increased 3%, or $23.7, primarily due to favorable pricing, currency, and equity affiliates' income, partially offset by lower volumes and higher costs, including higher planned maintenance. Adjusted EBITDA margin of 39.2% decreased 110 bp from 40.3% in the prior year, primarily due to the lower volumes and higher costs, partially offset by higher pricing.
Effective Tax Rate
The effective tax rate equals the income tax provision divided by income from continuing operations before taxes. The effective tax rate was 19.3% and 19.8% for the first quarters of fiscal years 2021 and 2020, respectively. The lower current year rate includes the impact of an agreement reached with foreign tax authorities that resolved uncertainties related to unrecognized tax benefits, partially offset by reductions in U.S. benefits on foreign derived income and the impact of enacted foreign tax rate changes.
Discussion of Segment Results
Industrial Gases – Americas
| Three Months Ended 31 December 2020 | 2019 | $ Change | % Change | |
|---|---|---|---|---|
| Sales | $933.0 | $936.2 | ($3.2) | —% |
| Operating income | 225.8 | 257.2 | (31.4) | (12%) |
| Operating margin | 24.2% | 27.5% | (330) bp | |
| Equity affiliates’ income | 22.3 | 20.6 | 1.7 | 8% |
| Adjusted EBITDA | 399.9 | 409.6 | (9.7) | (2%) |
| Adjusted EBITDA margin | 42.9% | 43.8% | (90) bp |
| Sales % Change from Prior Year | |
|---|---|
| Volume | (5)% |
| Price | 3% |
| Energy and natural gas cost pass-through | 2% |
| Currency | —% |
| Total Industrial Gases – Americas Sales Change | —% |
Sales of $933.0 were flat as positive pricing of 3% and higher energy and natural gas cost-pass through of 2% were offset by lower volumes of 5%. The pricing improvement was driven by our merchant business. Lower volumes were driven by lower demand from COVID-19, which began impacting this segment at the end of March 2020. This impact was partially offset by positive contributions from hydrogen assets we acquired in April 2020. Currency was flat versus the prior year.
Operating income of $225.8 decreased 12%, or $31.4. The decrease was primarily driven by lower volumes of $33 and higher net operating costs of $26, which were largely attributable to higher planned maintenance. These factors were partially offset by higher pricing, net of power and fuel costs, of $27. Operating margin of 24.2% decreased 330 bp from 27.5% in the prior year, primarily due to the higher net operating costs and lower volumes, partially offset by higher pricing.
Equity affiliates’ income of $22.3 increased 8%, or $1.7, primarily driven by higher income from affiliates in Mexico.
Industrial Gases – EMEA
| Three Months Ended 31 December 2020 | 2019 | $ Change | % Change | |
|---|---|---|---|---|
| Sales | $563.0 | $498.7 | $64.3 | 13% |
| Operating income | 141.5 | 120.5 | 21.0 | 17% |
| Operating margin | 25.1% | 24.2% | 90 bp | |
| Equity affiliates’ income | 25.0 | 19.3 | 5.7 | 30% |
| Adjusted EBITDA | 221.9 | 188.2 | 33.7 | 18% |
| Adjusted EBITDA margin | 39.4% | 37.7% | 170 bp |
| Sales % Change from Prior Year | |
|---|---|
| Volume | 5% |
| Price | 3% |
| Energy and natural gas cost pass-through | (1)% |
| Currency | 6% |
| Total Industrial Gases – EMEA Sales Change | 13% |
Sales of $563.0 increased 13%, or $64.3, as favorable currency of 6%, higher volumes of 5%, and positive pricing of 3% were partially offset by lower energy and natural gas cost-pass through to customers of 1%. Favorable currency was primarily driven by the appreciation of the Euro against the U.S. Dollar. Volumes improved 5% on contributions from our onsite business and the acquisition of an Israeli industrial gas business, primarily offering merchant gas products, in July 2020. These factors were partially offset by lower packaged gas demand from COVID-19, which began impacting this segment at the end of March 2020. The pricing improvement was primarily attributable to our merchant business.
Operating income of $141.5 increased 17%, or $21.0, primarily due to higher pricing, net of power and fuel costs, of $14 and favorable currency of $6. Operating margin of 25.1% increased 90 bp from 24.2% in the prior year, primarily due to favorable pricing, partially offset by unfavorable volume mix.
Equity affiliates’ income of $25.0 increased 30%, or $5.7, primarily due to higher income from affiliates in Saudi Arabia and Italy.
Industrial Gases – Asia
| Three Months Ended 31 December 2020 | 2019 | $ Change | % Change | |
|---|---|---|---|---|
| Sales | $717.5 | $692.8 | $24.7 | 4% |
| Operating income | 214.8 | 228.5 | (13.7) | (6%) |
| Operating margin | 29.9% | 33.0% | (310) bp | |
| Equity affiliates’ income | 19.9 | 16.9 | 3.0 | 18% |
| Adjusted EBITDA | 342.6 | 347.0 | (4.4) | (1%) |
| Adjusted EBITDA margin | 47.7% | 50.1% | (240) bp |
| Sales % Change from Prior Year | |
|---|---|
| Volume | (4)% |
| Price | 1% |
| Energy and natural gas cost pass-through | 1% |
| Currency | 6% |
| Total Industrial Gases – Asia Sales Change | 4% |
33
Sales of $717.5 increased 4%, or $24.7, as favorable currency of 6%, positive pricing, primarily on our merchant products, of 1%, and higher energy and natural gas cost pass-through to customers of 1% were partially offset by lower volumes of 4%. The favorable currency impact was primarily attributable to the appreciation of the Chinese Renminbi against the U.S. Dollar. The reduced contribution from Lu'An more than offset volume improvements from new plants, while the merchant business remained stable.
Operating income of $214.8 decreased 6%, or $13.7, primarily due to lower volumes of $33, partially offset by favorable currency of $14 and positive pricing, net of power and fuel costs, of $5. Operating margin of 29.9% decreased 310 bp from 33.0% in the prior year, primarily due to reduced volume contribution from Lu'An.
Equity affiliates’ income of $19.9 increased 18%, or $3.0, primarily due to higher income from an affiliate in India.
Industrial Gases – Global
The Industrial Gases – Global segment includes sales of cryogenic and gas processing equipment for air separation and centralized global costs associated with management of all the Industrial Gases segments.
| Three Months Ended 31 December 2020 | 2019 | $ Change | % Change | |
|---|---|---|---|---|
| Sales | $104.5 | $92.6 | $11.9 | 13% |
| Operating (loss) income | (4.6) | 3.6 | (8.2) | (228%) |
| Adjusted EBITDA | 0.1 | 7.4 | (7.3) | (99%) |
Sales of $104.5 increased 13%, or $11.9, primarily due to higher sale of equipment activity. Despite higher sales, operating loss of $4.6 increased $8.2 from income of $3.6 in the prior year due to higher product development spending. Income from the settlement of a supply contract in the first quarter of 2021 offset income from project activities in the prior year.
Corporate and other
The Corporate and other segment includes our liquefied natural gas ("LNG"), turbo machinery equipment and services, and distribution sale of equipment businesses as well as corporate support functions that benefit all segments. The results of the Corporate and other segment also include income and expense that is not directly associated with the other segments, such as foreign exchange gains and losses.
| Three Months Ended 31 December 2020 | 2019 | $ Change | % Change | |
|---|---|---|---|---|
| Sales | $57.2 | $34.4 | $22.8 | 66% |
| Operating loss | (38.4) | (48.8) | 10.4 | 21% |
| Adjusted EBITDA | (32.4) | (43.8) | 11.4 | 26% |
Sales of $57.2 increased 66%, or $22.8, and operating loss of $38.4 decreased 21%, or $10.4, primarily due to higher LNG sale of equipment activity.
RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES
(Millions of dollars unless otherwise indicated, except for per share data)
We present certain financial measures, other than in accordance with U.S. generally accepted accounting principles ("GAAP"), on an "adjusted" or "non-GAAP" basis. On a consolidated basis, these measures include adjusted diluted earnings per share ("EPS"), adjusted EBITDA, adjusted EBITDA margin, and adjusted effective tax rate. On a segment basis, these measures include adjusted EBITDA and adjusted EBITDA margin. In addition to these measures, we also present certain supplemental non-GAAP financial measures to help the reader understand the impact that certain disclosed items, or "non-GAAP adjustments," have on the calculation of our adjusted diluted EPS. For each non-GAAP financial measure, we present a reconciliation to the most directly comparable financial measure calculated in accordance with GAAP.
Our non-GAAP financial measures are not meant to be considered in isolation or as a substitute for the most directly comparable measure calculated in accordance with GAAP. We believe these non-GAAP financial measures provide investors, potential investors, securities analysts, and others with useful information to evaluate the performance of our business because such measures, when viewed together with financial results computed in accordance with GAAP, provide a more complete understanding of the factors and trends affecting our historical financial performance and projected future results.
In many cases, non-GAAP financial measures are determined by adjusting the most directly comparable GAAP measure to exclude non-GAAP adjustments that we believe are not representative of our underlying business performance. For example, we previously excluded certain expenses associated with cost reduction actions, impairment charges, and gains on disclosed transactions. The reader should be aware that we may recognize similar losses or gains in the future. Readers should also consider the limitations associated with these non-GAAP financial measures, including the potential lack of comparability of these measures from one company to another.
When applicable, the tax impact on our pre-tax non-GAAP adjustments reflects the expected current and deferred income tax impact of our non-GAAP adjustments. These tax impacts are primarily driven by the statutory tax rate of the various relevant jurisdictions and the taxability of the adjustments in those jurisdictions.
ADJUSTED DILUTED EPS
There were no non-GAAP adjustments in the first quarter of fiscal year 2021 or 2020 that impacted diluted EPS.
When applicable, the table below provides a reconciliation to the most directly comparable GAAP measure for each of the major components used to calculate adjusted diluted EPS from continuing operations, which we view as a key performance metric. In periods that we have non-GAAP adjustments, we believe it is important for the reader to understand the per share impact of each such adjustment because management does not consider these impacts when evaluating underlying business performance.
| Q1 2021 vs. Q1 2020 | Operating Income | Equity Affiliates' Income | Income Tax Provision | Net Income Attributable to Air Products | Diluted EPS |
|---|---|---|---|---|---|
| 2021 GAAP | $539.1 | $69.3 | $113.9 | $471.7 | $2.12 |
| No non-GAAP adjustments | — | — | — | — | — |
| 2021 Non-GAAP Measure ("Adjusted") | $539.1 | $69.3 | $113.9 | $471.7 | $2.12 |
| 2020 GAAP | $561.0 | $58.2 | $120.7 | $475.6 | $2.14 |
| No non-GAAP adjustments | — | — | — | — | — |
| 2020 Non-GAAP Measure ("Adjusted") | $561.0 | $58.2 | $120.7 | $475.6 | $2.14 |
| Change GAAP and Non-GAAP Measure ("Adjusted") | ($0.02) | ||||
| % Change GAAP and Non-GAAP Measure ("Adjusted") | (1%) |
35
ADJUSTED EBITDA AND ADJUSTED EBITDA MARGIN
We define adjusted EBITDA as net income less income (loss) from discontinued operations, net of tax, and excluding non-GAAP adjustments, which we do not believe to be indicative of underlying business trends, before interest expense, other non-operating income (expense), net, income tax provision, and depreciation and amortization expense. Adjusted EBITDA and adjusted EBITDA margin provide useful metrics for management to assess operating performance. Margins are calculated independently for each period by dividing each line item by consolidated sales for the respective period and may not sum to total margin due to rounding.
The table below presents consolidated sales and a reconciliation of net income on a GAAP basis to adjusted EBITDA and net income margin on a GAAP basis to adjusted EBITDA margin:
| Three Months Ended 31 December 2020 $Margin | 2019 $Margin | |||
|---|---|---|---|---|
| Sales | $2,375.2 | $2,254.7 | ||
| Net income and net income margin | $486.7 | 20.5% | $488.9 | 21.7% |
| Less: Income from discontinued operations, net of tax | 10.3 | 0.4% | — | —% |
| Add: Interest expense | 36.7 | 1.5% | 18.7 | 0.8% |
| Less: Other non-operating income (expense), net | 18.6 | 0.8% | 9.1 | 0.4% |
| Add: Income tax provision | 113.9 | 4.8% | 120.7 | 5.4% |
| Add: Depreciation and amortization | 323.7 | 13.6% | 289.2 | 12.8% |
| Adjusted EBITDA and adjusted EBITDA margin | $932.1 | 39.2% | $908.4 | 40.3% |
| Q1 2021 vs. Q1 2020 Change GAAP | |
|---|---|
| Net income $ change | ($2.2) |
| Net income % change | —% |
| Net income margin change | (120) bp |
| Change Non-GAAP | |
| Adjusted EBITDA $ change | $23.7 |
| Adjusted EBITDA % change | 3% |
| Adjusted EBITDA margin change | (110) bp |
36
The tables below present sales and a reconciliation of operating income and operating margin by segment to adjusted EBITDA and adjusted EBITDA margin by segment for the three months ended 31 December 2020 and 2019:
| Sales | Industrial Gases– Americas | Industrial Gases– EMEA | Industrial Gases– Asia | Industrial Gases– Global | Corporate and other | Total |
|---|---|---|---|---|---|---|
| Q1 2021 | $933.0 | $563.0 | $717.5 | $104.5 | $57.2 | $2,375.2 |
| Q1 2020 | 936.2 | 498.7 | 692.8 | 92.6 | 34.4 | 2,254.7 |
| Q1 2021 GAAP Measures | Industrial Gases– Americas | Industrial Gases– EMEA | Industrial Gases– Asia | Industrial Gases– Global | Corporate and other | Total |
|---|---|---|---|---|---|---|
| Operating income (loss) | $225.8 | $141.5 | $214.8 | ($4.6) | ($38.4) | $539.1 |
| Operating margin | 24.2% | 25.1% | 29.9% | |||
| Q1 2020 GAAP Measures | ||||||
| Operating income (loss) | $257.2 | $120.5 | $228.5 | $3.6 | ($48.8) | $561.0 |
| Operating margin | 27.5% | 24.2% | 33.0% | |||
| Q1 2021 vs. Q1 2020 Change GAAP | ||||||
| Operating income/loss $ change | ($31.4) | $21.0 | ($13.7) | ($8.2) | $10.4 | |
| Operating income/loss % change | (12%) | 17% | (6%) | (228%) | 21% | |
| Operating margin change | (330) bp | 90 bp | (310) bp | |||
| Q1 2021 Non-GAAP Measures | ||||||
| Operating income (loss) | $225.8 | $141.5 | $214.8 | ($4.6) | ($38.4) | $539.1 |
| Add: Depreciation and amortization | 151.8 | 55.4 | 107.9 | 2.6 | 6.0 | 323.7 |
| Add: Equity affiliates' income | 22.3 | 25.0 | 19.9 | 2.1 | — | 69.3 |
| Adjusted EBITDA | $399.9 | $221.9 | $342.6 | $0.1 | ($32.4) | $932.1 |
| Adjusted EBITDA margin | 42.9% | 39.4% | 47.7% | |||
| Q1 2020 Non-GAAP Measures | ||||||
| Operating income (loss) | $257.2 | $120.5 | $228.5 | $3.6 | ($48.8) | $561.0 |
| Add: Depreciation and amortization | 131.8 | 48.4 | 101.6 | 2.4 | 5.0 | 289.2 |
| Add: Equity affiliates' income | 20.6 | 19.3 | 16.9 | 1.4 | — | 58.2 |
| Adjusted EBITDA | $409.6 | $188.2 | $347.0 | $7.4 | ($43.8) | $908.4 |
| Adjusted EBITDA margin | 43.8% | 37.7% | 50.1% | |||
| Q1 2021 vs. Q1 2020 Change Non-GAAP | ||||||
| Adjusted EBITDA $ change | ($9.7) | $33.7 | ($4.4) | ($7.3) | $11.4 | |
| Adjusted EBITDA % change | (2%) | 18% | (1%) | (99%) | 26% | |
| Adjusted EBITDA margin change | (90) bp | 170 bp | (240) bp |
37
ADJUSTED EFFECTIVE TAX RATE
There were no non-GAAP adjustments in the first quarter of fiscal year 2021 or 2020 that impacted our effective tax rate.
When applicable, the tax impact of our pre-tax non-GAAP adjustments reflects the expected current and deferred income tax expense associated with each adjustment and is primarily dependent upon the statutory tax rate of the various relevant jurisdictions and the taxability of the adjustments in those jurisdictions.
| Three Months Ended 31 December 2020 | 2019 | |
|---|---|---|
| Income Tax Provision | $113.9 | $120.7 |
| No non-GAAP adjustments | — | — |
| Adjusted Income Tax Provision | $113.9 | $120.7 |
| Income From Continuing Operations Before Taxes | $590.3 | $609.6 |
| No non-GAAP adjustments | — | — |
| Adjusted Income From Continuing Operations Before Taxes | $590.3 | $609.6 |
| Effective and Adjusted Effective Tax Rate | 19.3% | 19.8% |
LIQUIDITY AND CAPITAL RESOURCES
Our cash balance and cash flows from operations are our primary sources of liquidity and are generally sufficient to meet our liquidity needs. In addition, we have the flexibility to access capital through a variety of financing activities, including accessing the capital markets, drawing upon our credit facility, or alternatively, accessing the commercial paper markets. At this time, we have not utilized, nor do we expect to access, our credit facility for additional liquidity. In addition, we have considered the impacts of COVID-19 on our liquidity and capital resources and do not expect it to impact our ability to meet future liquidity needs.
As of 31 December 2020, we had $1,376.9 of foreign cash and cash items compared to total cash and cash items of $5,788.0. We do not expect that a significant portion of the earnings of our foreign subsidiaries and affiliates will be subject to U.S. income tax upon repatriation to the U.S. Depending on the country in which the subsidiaries and affiliates reside, the repatriation of these earnings may be subject to foreign withholding and other taxes. However, since we have significant current investment plans outside the U.S., it is our intent to permanently reinvest the majority of our foreign cash and cash items that would be subject to additional taxes outside the U.S.
The table below summarizes our cash flows from operating, investing, and financing activities as reflected on the consolidated statements of cash flows:
| Cash Provided By (Used For) | Three Months Ended 31 December 2020 | 2019 |
|---|---|---|
| Operating activities | $774.7 | $667.0 |
| Investing activities | 18.2 | (260.7) |
| Financing activities | (307.1) | (270.3) |
Operating Activities
For the first three months of fiscal year 2021, cash provided by operating activities was $774.7. Income from continuing operations of $471.7 was adjusted for items including depreciation and amortization, deferred income taxes, undistributed earnings of equity method investments, gains on sale of assets and investments, share-based compensation, and noncurrent lease receivables. The working capital accounts were a use of cash of $107.4, primarily driven by $47.5 from other working capital and $44.1 from trade receivables, less allowances. The use within "Other working capital" was primarily due to contract fulfillment costs related to sale of equipment projects. The use of cash within trade receivables, less allowances primarily resulted from increased sale of equipment activity.
For the first three months of fiscal year 2020, cash provided by operating activities was $667.0 which included income from continuing operations of $475.6. The working capital accounts were a use of cash of $163.1, primarily driven by $115.4 from payables and accrued liabilities and $41.6 from other working capital. The use of cash within “Payables and accrued liabilities” was primarily driven by a $45.2 decrease in accrued incentive compensation due to payments on the 2019 annual incentive compensation plan and $24.9 from the maturity of a forward exchange contract that hedged a foreign currency exposure. The use of other working capital was primarily due to an increase in contract assets and contract fulfillment costs associated with revenue generating project activity.
Cash paid for income taxes, net of cash refunds, was $73.4 and $66.2 for the three months ended 31 December 2020 and 2019, respectively.
Investing Activities
For the first three months of fiscal year 2021, cash provided by investing activities was $18.2. Capital expenditures for plant and equipment were $664.2. Proceeds from investments of $855.0 resulted from maturities of time deposits and treasury securities with terms greater than three months and less than one year and exceeded purchases of investments of $158.5.
For the first three months of fiscal year 2020, cash used for investing activities was $260.7. Capital expenditures for plant and equipment were $447.7. Proceeds from investments of $177.0 resulted from maturities of time deposits with original terms greater than three months but less than one year.
Capital expenditures is a non-GAAP measure that we define as cash flows for additions to plant and equipment, including long-term deposits, acquisitions (less cash acquired), and investment in and advances to unconsolidated affiliates. A reconciliation of cash used for investing activities to our reported capital expenditures is provided below:
| Three Months Ended 31 December 2020 | 2019 | |
|---|---|---|
| Cash (provided by) used for investing activities | ($18.2) | $260.7 |
| Proceeds from sale of assets and investments | 2.6 | 15.2 |
| Purchases of investments | (158.5) | — |
| Proceeds from investments | 855.0 | 177.0 |
| Other investing activities | 3.3 | 1.9 |
| Capital Expenditures | $684.2 | $454.8 |
The components of our capital expenditures are detailed in the table below:
| Three Months Ended 31 December 2020 | 2019 | |
|---|---|---|
| Additions to plant and equipment, including long-term deposits | $664.2 | $447.7 |
| Investment in and advances to unconsolidated affiliates | 20.0 | 7.1 |
| Capital Expenditures | $684.2 | $454.8 |
Capital expenditures for the first three months of fiscal year 2021 totaled $684.2 compared to $454.8 for the first three months of fiscal year 2020. The increase was primarily driven by spending on gasification projects. Additions to plant and equipment also included support capital of a routine, ongoing nature, including expenditures for distribution equipment and facility improvements.
Due to the significant uncertainty that remains regarding the duration of COVID-19, the pace of recovery, and its negative impact on the global economy, we are not providing capital expenditure guidance for fiscal year 2021. We are monitoring our projects to determine whether capital spending and project onstream timing may be delayed for those currently under construction.
Financing Activities
For the first three months of fiscal year 2021, cash used for financing activities was $307.1 and primarily included dividend payments to shareholders of $296.2.
For the first three months of fiscal year 2020, cash used for financing activities was $270.3 and primarily included dividend payments to shareholders of $255.7.
Financing and Capital Structure
Capital needs for the first three months of fiscal year 2021 were satisfied primarily with cash from operations. Total debt increased from $7,907.8 at 30 September 2020 to $8,006.9 at 31 December 2020. The current year total debt balance includes $355.5 of related party debt, primarily associated with the Lu'An joint venture.
We have a $2,300.0 five-year revolving credit agreement with a syndicate of banks (the "Credit Agreement”) maturing 31 March 2022. Under the Credit Agreement, senior unsecured debt is available to us and certain of our subsidiaries. The Credit Agreement provides us a source of liquidity and supports our commercial paper program. Our only financial covenant under the Credit Agreement is a maximum ratio of total debt to total capitalization, or total debt plus total equity, no greater than 70%. Total debt as of 31 December 2020 and 30 September 2020, expressed as a percentage of total capitalization, defined as total debt plus total equity, was 38.0% and 38.9%, respectively.
There were no outstanding commitments maintained by our foreign subsidiaries as of 31 December 2020.
As of 31 December 2020, we were in compliance with all of the financial and other covenants under our debt agreements.
On 15 September 2011, the Board of Directors authorized the repurchase of up to $1,000 of our outstanding common stock. We did not purchase any of our outstanding shares during the first three months of fiscal year 2021. As of 31 December 2020, $485.3 in share repurchase authorization remained.
Dividends
On 28 January 2021, the Board of Directors increased the quarterly dividend on our common stock to $1.50 per share, representing a 12% increase from the previous dividend of $1.34 per share. This is the 39th consecutive year that we have increased our quarterly dividend payment. The dividend is payable on 10 May 2021 to shareholders of record as of 1 April 2021.
CONTRACTUAL OBLIGATIONS
We are obligated to make future payments under various contracts, such as debt agreements, lease agreements, unconditional purchase obligations, and other long-term obligations.
We entered into additional operating lease commitments in the first quarter of fiscal year 2021 with lease terms that commence after 31 December 2020. Refer to Note 10, Commitments and Contingencies, to the consolidated financial statements for additional information.
There have been no other material changes to our contractual obligations since 30 September 2020.
PENSION BENEFITS
For the three months ended 31 December 2020 and 2019, net periodic pension (benefit) cost was ($9.5) and $0.4, respectively. We recognized service-related costs of $11.4 and $11.9, respectively, on our consolidated income statements within operating income. The non-service related benefits of $20.9 and $11.5 were included in "Other non-operating income (expense), net" for the three months ended 31 December 2020 and 2019, respectively. The increase to pension income in fiscal year 2021 from an expense in fiscal year 2020 resulted from lower interest cost and higher total assets. The amount of service costs capitalized in the first three months of fiscal years 2021 and 2020 were not material.
We expect total pension settlement losses of approximately $0 to $5 in fiscal year 2021.
Management considers various factors when making pension funding decisions, including tax, cash flow, and regulatory implications. For the three months ended 31 December 2020 and 2019, our cash contributions to funded pension plans and benefit payments for unfunded pension plans were $21.2 and $8.3, respectively. Total contributions for fiscal year 2021 are expected to be approximately $45 to $55. We do not expect COVID-19 to impact our contribution forecast for fiscal year 2021. During fiscal year 2020, total contributions were $37.5.
Refer to Note 9, Retirement Benefits, to the consolidated financial statements for details on pension cost and cash contributions.
COMMITMENTS AND CONTINGENCIES
Refer to Note 10, Commitments and Contingencies, to the consolidated financial statements for information concerning our commitments and contingencies, including litigation and environmental matters.
OFF-BALANCE SHEET ARRANGEMENTS
There have been no material changes to off-balance sheet arrangements since 30 September 2020. We are not a primary beneficiary in any material variable interest entity. Our off-balance sheet arrangements are not reasonably likely to have a material impact on financial condition, changes in financial condition, results of operations, or liquidity.
RELATED PARTY TRANSACTIONS
See Note 15, Supplemental Information, to the consolidated financial statements for information concerning activity with our related parties.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
Management’s Discussion and Analysis of our financial condition and results of operations is based on the consolidated financial statements and accompanying notes that have been prepared in accordance with GAAP. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Judgments and estimates of uncertainties are required in applying our accounting policies in many areas. However, application of policies that management has identified as critical places significant importance on management’s judgment, often as the result of the need to make estimates of matters that are inherently uncertain. If actual results were to differ materially from these estimates, the reported results could be materially affected. A description of our major accounting policies, including those identified as critical, is included in our 2020 Form 10-K.
There have been no changes to our accounting policies or estimates during the first three months of fiscal year 2021 that had a significant impact on our financial condition, change in financial condition, liquidity, or results of operations.
While our results of operations have been negatively affected by COVID-19 as of and for the three months ended 31 December 2020, there has been no triggering event that would require interim impairment testing for any of our asset groups, reporting units that contain goodwill, indefinite-lived intangible assets, or equity method investments. We will continue to evaluate the nature and extent of COVID-19 impacts on our business and any impact they may have on management's estimates, particularly those for our Latin America business. The duration and severity of the COVID-19 outbreak and its long-term impact on our business is uncertain.
NEW ACCOUNTING GUIDANCE
See Note 2, New Accounting Guidance, to the consolidated financial statements for information concerning the implementation and impact of new accounting guidance.
Market risk
As filed, 1,762 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Information on our utilization of financial instruments and an analysis of the sensitivity of these instruments to selected changes in market rates and prices is included in our 2020 Form 10-K.
Our net financial instrument position increased from a liability of $8,220.7 at 30 September 2020 to a liability of $8,484.9 at 31 December 2020. The increase was due to the strengthening of the Euro and Chinese Renminbi against the U.S. Dollar.
Interest Rate Risk
The sensitivity analysis related to the interest rate risk on the fixed portion of our debt portfolio assumes an instantaneous 100 bp move in interest rates from the level at 31 December 2020, with all other variables held constant. A 100 bp increase in market interest rates would result in a decrease of $683 and $711 in the net liability position of financial instruments at 31 December 2020 and 30 September 2020, respectively. A 100 bp decrease in market interest rates would result in an increase of $809 and $846 in the net liability position of financial instruments at 31 December 2020 and 30 September 2020.
There were no material changes to the sensitivity analysis related to the variable portion of our debt portfolio since 30 September 2020.
Foreign Currency Exchange Rate Risk
The sensitivity analysis related to foreign currency exchange rates assumes an instantaneous 10% change in foreign currency exchange rates from their levels at 31 December 2020, with all other variables held constant. A 10% strengthening or weakening of the functional currency of an entity versus all other currencies would result in a decrease or increase, respectively, of $389 and $360 in the net liability position of financial instruments at 31 December 2020 and 30 September 2020, respectively.
Controls and procedures
As filed, 913 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Disclosure Controls and Procedures
We maintain a comprehensive set of disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Under the supervision of the Chief Executive Officer and Chief Financial Officer, our management conducted an evaluation of the effectiveness of our disclosure controls and procedures as of 31 December 2020. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of 31 December 2020, our disclosure controls and procedures were effective.
Internal Control Over Financial Reporting
There was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended 31 December 2020 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2020-10-01 to 2020-12-31 | $2.38bn | us-gaap:Revenues |
| Cost of revenue | 3 months2020-10-01 to 2020-12-31 | $1.63bn | us-gaap:CostOfGoodsAndServicesSold |
| Research and development | 3 months2020-10-01 to 2020-12-31 | $23.5m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2020-10-01 to 2020-12-31 | $202.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2020-10-01 to 2020-12-31 | $539.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2020-10-01 to 2020-12-31 | $36.7m | us-gaap:InterestExpense |
| Income tax | 3 months2020-10-01 to 2020-12-31 | $113.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-10-01 to 2020-12-31 | $482.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2020-10-01 to 2020-12-31 | $2.17 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2020-10-01 to 2020-12-31 | $2.18 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2020-10-01 to 2020-12-31 | 222,600,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2020-10-01 to 2020-12-31 | $774.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2020-10-01 to 2020-12-31 | $664.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2020-10-01 to 2020-12-31 | $296.2m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2020-12-31 | $5.79bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-12-31 | $8.81bn | us-gaap:AssetsCurrent |
| Total assets | At period end2020-12-31 | $26.09bn | us-gaap:Assets |
| Current liabilities | At period end2020-12-31 | $2.99bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-12-31 | $13.02bn | us-gaap:Liabilities |
| Short-term borrowings | At period end2020-12-31 | $9.2m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2020-12-31 | $12.68bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2020-12-31 | 221,276,890 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000002969-21-000012. Last ingested by Listed: Nov 5, 2026, 11:28 ET. Listed shows no prices and gives no investment advice.